Header image
               
Preclinical evaluation of anti-VEGFR2 monoclonal antibody ramucirumab labelled with zirconium-89 for tumour imaging
        Preclinical evaluation of anti-VEGFR2 monoclonal antibody ramucirumab labelled with zirconium-89 for tumour imaging.        
                  Journal of Labelled Compounds & Radiopharmaceuticals.                
                  2021,
                
                              64(7),
                  
                              262-270,
                          
                  ISSN: 0362-4803,
                
                
                              PMID: 33818828,                          
                 
                          
        
      
    